We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection

    Objective

    To investigate the effect of antiviral therapy and drug withdrawal on the incidence of hepatitis B after delivery in pregnant women with...

    Minghui Li, Fangfang Sun, ... Yao **e in Hepatology International
    Article 15 September 2022
  2. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents

    The treatment of patients infected with the hepatitis C virus (HCV) has been revolutionised by the development of direct-acting antiviral agents...

    Michael Murray in Clinical Pharmacokinetics
    Article 20 September 2023
  3. Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases

    Background

    The severe fever with thrombocytopenia syndrome disease (SFTS), caused by the novel tick-borne SFTS virus (SFTSV), was listed among the top...

    Shu Shen, Yaxian Zhang, ... Fei Deng in BMC Medicine
    Article Open access 21 October 2022
  4. Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults

    Introduction

    Oral antiviral medications are important tools for preventing severe COVID-19 outcomes. However, their uptake remains low for reasons...

    Kate Penrose, Avantika Srivastava, ... Denis Nash in Infectious Diseases and Therapy
    Article Open access 23 June 2024
  5. Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study

    Background

    Congenital human cytomegalovirus (cCMV) infection can cause sensorineural hearing loss and neurodevelopmental disabilities in children....

    Yuka Torii, Kazuhiro Horiba, ... Yoshinori Ito in BMC Infectious Diseases
    Article Open access 22 June 2022
  6. Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era

    The impact of letermovir (LTV)—an anti-cytomegalovirus (CMV) drug—on human herpesvirus-6 (HHV-6) encephalitis is unclear. We hypothesized that LTV...

    Toshiki Terao, Ken-ichi Matsuoka, ... Hideki Nakasone in Bone Marrow Transplantation
    Article 25 May 2024
  7. Screening and verification of antiviral compounds against HSV-1 using a method based on a plaque inhibition assay

    Background

    Herpes simplex virus type 1 (HSV-1) infection is a common viral disease that mainly causes oral lesions, but can also cause genital lesions...

    Yingxian Yin, Jiahui Li, ... Yi Xu in BMC Infectious Diseases
    Article Open access 19 December 2023
  8. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

    Brief summary

    In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance.

    Background

    Favipiravir, an...

    Viravarn Luvira, William H. K. Schilling, ... Nicholas J. White in BMC Infectious Diseases
    Article Open access 15 January 2024
  9. Construction of recombinant fluorescent LSDV for high-throughput screening of antiviral drugs

    Lumpy skin disease virus (LSDV) infection is a major socio-economic issue that seriously threatens the global cattle-farming industry. Here, a...

    **gyu Wang, **zhao Ji, ... Shoujun Li in Veterinary Research
    Article Open access 16 March 2024
  10. Potential antiviral activities of chrysin against hepatitis B virus

    Background

    Interferon and nucleos(t)ide analogues are current therapeutic treatments for chronic Hepatitis B virus (HBV) infection with the...

    Sajad Ahmad Bhat, Syed Kazim Hasan, ... Syed Naqui Kazim in Gut Pathogens
    Article Open access 09 March 2023
  11. Cytomegalovirus enteritis resistant to antiviral drugs improved following total colectomy

    Background

    Cytomegalovirus (CMV) infection, often subclinical in childhood, is reactivated during a state of cell-mediated immunodeficiency. In cases...

    Sae Kawata, Jumpei Takamatsu, ... **koo Kang in Surgical Case Reports
    Article Open access 15 June 2023
  12. CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches

    Neurotropic viruses may cause meningitis, myelitis, encephalitis, or meningoencephalitis. These inflammatory conditions of the central nervous system...

    Ming Sun, Martijn L. Manson, ... Elizabeth C. M. de Lange in CNS Drugs
    Article Open access 05 April 2024
  13. GC–MS and ADME profile analysis of Carcinoscorpius rotundicauda bioactive compounds and their potential as COVID-19 antiviral

    Background

    Carcinoscorpius rotundicauda is a species of horseshoe crab that is rarely studied. This animal is often used as part of the blood as a...

    Ahmad Misbakhus Sururi, Dwi Anggorowati Rahayu, ... Mia Savita in Future Journal of Pharmaceutical Sciences
    Article Open access 11 December 2023
  14. Chinese herbal extracts with antiviral activity: evaluation, mechanisms, and potential for preventing PRV, PEDV and PRRSV infections

    The rapid expansion of large-scale pig farming has brought about a surge in viral diseases with high morbidity rates and diverse manifestations. This...

    Yumei Sun, Chang Li, ... Qigai He in Animal Diseases
    Article Open access 26 October 2023
  15. Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

    Introduction

    During the recent coronavirus disease 2019 (COVID-19) pandemic, preferences for factors associated with vaccines have been evaluated....

    Naoki Hosogaya, Takahiro Takazono, ... Hiroshi Mukae in Advances in Therapy
    Article Open access 12 June 2023
  16. SP2509, a specific antagonist of LSD1, exhibits antiviral properties against Porcine epidemic diarrhea virus

    Background

    Porcine epidemic diarrhea virus (PEDV), a type of coronavirus, is one of the main pathogens that can infect pigs of all ages. It causes...

    **nyu Zhao, Yuhang Zhang, ... **aofeng Zheng in BMC Veterinary Research
    Article Open access 10 May 2024
  17. Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study

    Background

    Kidney transplant recipients (KTRs) are at risk of severe coronavirus disease 2019 (COVID-19), and even now that Omicron subvariants have...

    Takashi Sakaguchi, Akihiko Mitsuke, ... Hideki Enokida in BMC Nephrology
    Article Open access 08 April 2024
  18. Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

    Purpose

    To investigate the clinical impact of three available antivirals for early COVID-19 treatment in a large real-life cohort.

    Methods ...
    Matteo Rinaldi, Caterina Campoli, ... Pierluigi Viale in BMC Infectious Diseases
    Article Open access 02 October 2023
  19. Effect of prophylactic antiviral intervention on T cell immunity in hepatitis B virus-infected pregnant women

    Background

    Antiviral intervention in hepatitis B virus (HBV)-infected pregnant women can effectively reduce mother-to-child transmission. However, the...

    Meiting Huang, Yunfei Gao, ... Zhihua Liu in BMC Pregnancy and Childbirth
    Article Open access 27 May 2023
Did you find what you were looking for? Share feedback.